Who Needs What When? | July 9, 2026
Date of Presentation: July 9, 2026
In this presentation, Dr. Greenlee reviews current evidence-based recommendations for the management of diabetic kidney disease, with a focus on appropriate use of urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) to guide screening, staging, and treatment decisions. She highlights current guideline recommendations for prescribing and monitoring angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin II receptor blockers (ARBs), and sodium-glucose cotransporter-2 (SGLT2) inhibitors, as well as practical strategies to optimize preventive care in the primary care setting.
Recording:
Presented by:
Dr. Mary Carol Greenlee
Faculty
Mary Carol Greenlee, MD, MACP, is board certified in internal medicine and in endocrinology, diabetes, and metabolism with over 30 years’ experience in private practice. Dr. Greenlee graduated Summa Cum Laude from Miami University (Ohio) and with Highest Distinction from Indiana University School of Medicine. She did her internal medicine internship and residency at Ball Memorial Hospital in Muncie, IN before returning to IU Medical Center for her fellowship in endocrinology. Carol chaired the “AID” project to develop shared decision-making tools for insulin therapy, as well as several workgroups focused on improving care coordination between primary and specialty care. She received NCQA recognition for Patient-Centered Specialty Care in 2014 and the Endocrine Society award for Outstanding Clinical Practitioner in 2016.
Read the full bio …Resources Provided:
Date added: July 8, 2026
